Drug intelligence / Profile preview

delta-9 tetrahydrocannabinol + melatonin

Development stage
Unknown
Lead developer
Mr Hemp Flower
Modality
Small Molecules
Administration
Oral
01

Overview

A **combination product** containing **delta-9 tetrahydrocannabinol (THC)**—the principal psychoactive cannabinoid of cannabis—and **melatonin**, a hormone regulating the sleep-wake cycle. Together, these agents are primarily formulated for sleep aid purposes, often as edible products (e.g., gummies) intended to initiate and improve sleep. THC exerts its effects mainly through activation of the cannabinoid type 1 receptor in the brain, which can decrease sleep onset latency and enhance melatonin production, thus amplifying sedative effects and sleep quality. Melatonin acts as an agonist at melatonin receptors (MT1, MT2) in the suprachiasmatic nucleus of the hypothalamus, enforcing sleep timing and circadian rhythm regulation. This combination is being investigated for insomnia and sleep disturbances, with preliminary data suggesting additive or synergistic sedative effects[3][5][7][6][2]. Brand manufacturers exist but no widely-recognized single brand name predominates; representative products are available from companies such as Mr. Hemp Flower and Apollo.

02

Targets

CNR1 (Cannabinoid receptor 1)MTNR1A (MT1)MTNR1B (Melatonin Receptor 2)

Beyond the preview

Go deeper on delta-9 tetrahydrocannabinol + melatonin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on delta-9 tetrahydrocannabinol + melatonin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call